2013
DOI: 10.1155/2013/426034
|View full text |Cite
|
Sign up to set email alerts
|

Full-Length Genomic Sequence of Subgenotype IIIA Hepatitis A Virus Isolate in Republic of Korea

Abstract: Hepatitis A virus is known to cause acute hepatitis and has significant implications for public health throughout the world. In the Republic of Korea, the number of patients with hepatitis A virus infection has been increasing rapidly since 2006. In this study, the Kor-HAV-F strain was identified as subgenotype IIIA by RT-PCR, and its identity was confirmed by nucleotide sequencing and alignment analysis. Moreover, detailed phylogenetic analysis indicated that the Kor-HAV-F strain clustered into subgenotype II… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 30 publications
(30 reference statements)
1
3
0
Order By: Relevance
“…Amino acid sequences of VP3-VP1 were compared with diverse subgenotype strains reported in various countries, and all samples from affected area II were identified to contain a unique amino acid, M519T, compared with those from affected area I and other reported IA strains from the DNA Data Bank. The samples from affected area II also had a unique amino acid, K813N, in VP1-P2A, whereas samples from affected area I did not exhibit K813 mutations, similar to previous reports from Indonesia and other countries (27,34,35). Thus, although these epidemics in the two areas occurred at a similar time and the causative epidemic agents were HAV-IA, they were different strains of HAV.…”
Section: Or -------------------------------------------------------Assupporting
confidence: 86%
“…Amino acid sequences of VP3-VP1 were compared with diverse subgenotype strains reported in various countries, and all samples from affected area II were identified to contain a unique amino acid, M519T, compared with those from affected area I and other reported IA strains from the DNA Data Bank. The samples from affected area II also had a unique amino acid, K813N, in VP1-P2A, whereas samples from affected area I did not exhibit K813 mutations, similar to previous reports from Indonesia and other countries (27,34,35). Thus, although these epidemics in the two areas occurred at a similar time and the causative epidemic agents were HAV-IA, they were different strains of HAV.…”
Section: Or -------------------------------------------------------Assupporting
confidence: 86%
“…This is not surprising, since approximately 80% of the human HAV strains isolated are type I, with most remaining human strains being type III [33]- [35]. Subgenotypes IA and IB are the most common found in Brazil, France, China, and Japan [36]. In this study, however, HAV sequences were classified as genotype IA which is endemic in North America [37].…”
Section: Discussionmentioning
confidence: 58%
“…To elucidate sequence identity, viral RNA was extracted using total nucleic acid isolation (TNAi) extraction methodologies on an Ampliprep instrument (Roche Ltd.). Rescued RNA was reverse transcribed and directly amplified with the SuperScript III one-step reverse transcription-PCR (RT-PCR) system with Platinum Taq HiFi (Invitrogen) using primer pairs described previously ( 3 , 4 ). In combination, these were as follows: GCCTAGGCTATAGGCTAAAT (HAV-1F) and CGTTCCCAACATCTGTGT (HAV-1R), GTTGTAAATATTAATTCCTGCAGG (HAV-2F) and CAGACAATCCACTTAATGCAT (HAV-2R), CTATGAAGAGATGCTTTGGAT (HAV-3F) and TGTATCTCAATTCCAAATCTTGC (HAV-3R), ATTCATTCTGCTGAYTGGTTG (HAV-4F) and CAACTGGRATAACCTTGATCT (HAV-4R), AGGAAGATTGGAAATCTGATG (HAV-5F) and TTCACTGTTGTAATRCCAACTTG (HAV-5R), CAAGTTGGCATTACAACAGTG (HAV-6F) and GAGCAATTCTATCCATCATTG (HAV-6R), GAAATGGATGCTGGAGTTTTTACT (HAV-7F) and CTGAACARATATCYCTAAGCC (HAV-7R), GTTGAGAGTGATGAATTATGC (HAV-8F) and YTGTCCACTATATCCATCCCA (HAV-8R) and AATGGTGMCAAGATGTGAGCC (HAV-9F) and AACTGCAACCCACTTRTGRTT (HAV-9R), GGGATTATCAGATGATGACAA (HAV-10F) and TACCTCTCCARGCTTGATCAA (HAV-10R), GGACTCCAATGTTAATTTCAG (HAV-11F) and TCCATATTRATTGCATCTATCCC (HAV-11R), GATGAGCCAGATGATTATAAAGA (HAV-12F) and AGAAGGCATTGAMCCACATAC (HAV-12R), GTATGTGGKTCAATGCCTTCT (HAV-13F) and WATTTACTGAAAAGAYAAAATAAACAAAC (HAV-13R), TTCAAGAGGGGTCTCCGG (HAV-1F) and GGAGAGCCCTGGAAGAAAGA (240R), TCACCGCCGTTTGCCTAG (68F) and AGGAATGAGGAAAAACCTAAA (725R), TTATGTGGTGTTTGCCTCTGAG (661F) and AACAAACCATGAGGATAAACT (1249R), ATTTGAGCTAGCGTGCTATGGTACCTGGTGACCA (1180F) and GTTAGAAGGAGAGGTCAATCTG (2115R), GTGAGTACACTGCCATTGG (2050F) and CATTTCCTAGGAGGTGG (3225R), CCAGAGCTCCATTGAACTC (3006F) and AACTGAACAACCAATATCTGC (3908R), CATAATTGGTTTGTTGAGAGTC (3875F) and ATGAATTCAGTCATGTTTTG (4985R), GACTGAATTCATGGAGTTG (4977F) and CATATCAAGATCTAGAAAATCATC (6225R), AACTGTAAATGGAACCCCTAT (5654F) and ATAATTCATCCCACTGTCTATC (6636R), GGGTAAGACTCAGTTAGTTGATG (6225F) and TTGTCCAATCAAATCAAGATTATC (7044R), and TTGTCCAATCAAATCAAGATTATC (6984F) and TTTTTTTTTTTTTTT (15dT).…”
Section: Genome Announcementmentioning
confidence: 99%